WWP2 ubiquitin ligase and its isoforms: New biological insight and promising disease targets

Cell Cycle

Volumn 10, Issue 15, 2011, Pages 2437-2439

  Chantry, Andrew ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Cancer; Cartilage; Signal transduction; Smads; TGF ; Ubiquitin ligase

Indexed keywords

ISOPROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN WWP2; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENICITY; CARTILAGE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; ENZYME ACTIVITY; GENE INACTIVATION; NONHUMAN; OSTEOARTHRITIS; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 79961108386     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.15.16874     Document Type: Review

References (17)

1. Kerscher O, Felberbaum R, Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 2006; 22:159-80; PMID: 16753028; DOI: 10.1146/annurev.cellbio.22.010605.093503.
2. Navon A, Ciechanover A. The 26S Proteasome: From Basic Mechanisms to Drug Targeting. J Biol Chem 2009; 284:33713-8; PMID: 19812037; DOI: 10.1074/jbc.R109.018481.
3. Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, Orth A, et al. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS ONE 2008; 3:1487; PMID: 18213395; DOI: 10.1371/journal.pone.0001487.
4. van Leeuwen IM, Laín S. Pharmacological manipulation of the cell cycle and metabolism to protect normal tissues against conventional anticancer drugs. Oncotarget 2011; 2:274-6; PMID: 21512204.
5. Rotin D, Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol 2009; 10:398-409; PMID: 19436320; DOI: 10.1038/nrm2690.
6. Zou W, Chen X, Shim JH, Huang Z, Brady N, Hu D, et al. The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of Goosecoid. Nat Cell Biol 2011; 13:59-65; PMID: 21170031; DOI: 10.1038/ncb2134.
7. Nakamura Y, Yamamoto K, He X, Otsuki B, Kim Y, Murao H, et al. Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat Commun 2011; 2:251; PMID: 21427722; DOI: 10.1038/ncomms1242.
8. Maddika S, Kavela S, Rani N, Palicharla VR, Pokorny JL, Sarkaria JN, Chen J. WWP2 is an E3 ubiquitin ligase for PTEN. Nat Cell Biol 2011; May 1; [Epub ahead of print].
9. Soond SM, Chantry A. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT. Oncogene 2011; 30:2451-62; PMID: 21258410; DOI: 10.1038/onc.2010.617.
10. van der Kraan PM, Blaney Davidson EN, Blom A, van den Berg WB. TGFβ signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage 2009; 17:1539-45; PMID: 19583961; DOI: 10.1016/j.joca.2009.06.008.
11. Blaney Davidson EN, van der Kraan PM, van den Berg WB. TGFβ and osteoarthritis. Osteoarthritis Cartilage 2007; 15:597-604; PMID: 17391995; DOI: 10.1016/j.joca.2007.02.005.
12. Xu H, Wang W, Li C, Yu H, Yang A, Wang B, et al. WWP2 promotes degradation of transcription factor OCT4 in human embryonic stem cells. Cell Res 2009; 19:561-73; PMID: 19274063; DOI: 10.1038/cr.2009.31.
13. Liao B, Jin Y. Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner. Cell Res 2010; 20:332-44; PMID: 19997087; DOI: 10.1038/cr.2009.136.
14. Stefanovic S, Pucéat M. Oct-3/4: not just a gatekeeper of pluripotency for embryonic stem cell, a cell fate instructor through a gene dosage effect. Cell Cycle 2007; 6:8-10; PMID: 17245123; DOI: 10.4161/cc.6.1.3633.
15. Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, et al. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J 2010; 29:3286-300; PMID: 20711167; DOI: 10.1038/emboj.2010. 195.
16. Verdecia MA, Joazeiro CA, Wells NJ, Ferrer JL, Bowman ME, Hunter T, et al. Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase. Mol Cell 2003; 11:249-59; PMID: 12535537; DOI: 10.1016/S1097-2765(02)00774-8.
17. Qi J, Pellecchia M, Ronai ZA. The Siah2-HIFFoxA2 axis in prostate cancer - new markers and therapeutic opportunities. Oncotarget 2010; 1:379-85; PMID: 21037926.